title: Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes.
authors.affiliation: St Louis College of Pharmacy, St Louis, MO, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Thacker
authors.forename: G R
authors.initials: GR
authors.lastname: Grice
authors.forename: P E
authors.initials: PE
authors.lastname: Milligan
authors.forename: B F
authors.initials: BF
authors.lastname: Gage
mesh_terms: D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D065729:Cytochrome P-450 CYP2C9; D005820:Genetic Testing / Q000191:economics; D005838:Genotype; D006801:Humans; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D016032:Randomized Controlled Trials as Topic; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases